The Silk-Road Forum of Kidney Disease, held from August 16 to 18, 2018 in Lanzhou (China), was a valuable platform for nephrologists from North West China and Middle Asia to learn, interact and build their knowledge of nephrology. Endorsed by ISN and attended by ISN President David Harris, it was organized by the National Clinical...
Once a month, we collect and publish a list of important nephrology trials from the latest medical literature. Each trial is reviewed in context and their risk of bias in seven key areas assessed. The ISN-ACT is an initiative of the ISN intended to leverage existing infrastructures within ISN, in order to improve global nephrology community...
Many thanks to everybody who responded to the ISN-ACT toolkit questionnaire. Responses revealed a strong interest in getting more guidance to design and conduct clinical trials. This information will contribute to the ongoing development of an ISN-ACT clinical trials toolkit. Responses were received from 92 centers with varying levels of experience in designing, leading or...
Children of African descent are three times more vulnerable to chronic kidney disease (CKD). There also exists limited data on the GFR-based evaluation of renal function in sub-Saharan Africa compared to hospital-based data, which may not be representative of the general population. An eight-month study supported by an ISN Clinical Research grant seeks to determine the prevalence of...
We are pleased to share the results of the Clinical Research Program Grant application session that was held in October 2017. Each grant helps implement research projects to detect and manage chronic kidney disease, hypertension and diabetes in low-to-middle income countries. Congratulations to the teams behind these four applications! They will each receive between 10,000...
ISN and the French-speaking Society of Nephrology, Dialysis and Transplantation (SFNDT) have signed a partnership to express their mutual commitment in advancing nephrology in French-speaking Africa. This partnership with ISN and SNDTF will support the organization of joint ISN Continuing Medical Education (CMEs) and Clinical Research Programs, focusing on francophone Africa and starting in 2018. These CMEs...
This recent commentary featured in The Lancet Diabetes Endocrinal 2017 focuses on the need for coordinated efforts and a large international database of patients with diabetes and nephropathy. It refers to ISN and its Advancing Clinical Trials group and Clinical Trial Networks who could be instrumental in achieving this objective. Read more HERE.
The ISN Clinical Research Program Committee is pleased to announce the results of the May 2017 application round. ISN will fund four project following this recent call for applications. Congratulations to everybody involved in the following projects: Geraldo Bezerra da Silva Junior, Renal Health self-monitoring application (Brazil) Khaled Mohamed Amin El-zorkany, CKD screening in Menoufia and Assiut...
There is nothing new about the disparity that exists regarding specific health needs and clinical challenges in the developed and resource limited nations. Are medical advances that emerge in clinical research from the developed nations truly relevant and applicable to the rest of the world? To dig further into this issue, the ISN Clinical Research...
Every month, the ISN-Advancing Clinical Trials (ACT) will share a 'must-read trials list’ highlighting and sometimes analyzing important nephrology trials from the latest medical literature. The inaugural May edition is now available on ISN Academy. Get more information, HERE.
